EN-374

N/A

Report date: 2025/12/11 17:52:53

Base Information

Drug NameEN-374
Drug Alias NameEN-374
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionNADPH Oxidase 2 gene transference
TargetsNADPH Oxidase 2
Therapy Area/IndicationsGranulomatous Disease, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnsoma Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsoma Inc
Inactive CompaniesN/A
Active IndicationsGranulomatous Disease, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A